Molecular neurology of prion disease

被引:157
作者
Collinge, J [1 ]
机构
[1] Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England
关键词
D O I
10.1136/jnnp.2004.048660
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Prions are infectious pathogens principally composed of abnormal forms of a protein encoded in the host genome. They cause lethal neurodegenerative conditions including CJD, GSS, and kuru in humans and scrapie and bovine spongiform encephalopathy in domestic animals. Remarkably, distinct strains of prions occur despite absence of an agent-specific genome: misfolded proteins themselves may encode strain diversity - with wide implications in biology. The arrival of variant CJD, and the experimental confirmation that it is caused by infection with BSE-like prions, has focussed research on early diagnosis and treatment. Recent advances lead to considerable optimism that effective human therapies may now be developed. While several drugs have been tried in small numbers of patients, there is no clear evidence of efficacy of any agent and controlled clinical trials are urgently needed. Importantly, there is increasing recognition that fundamental processes involved in prion propagation seeded aggregation of misfolded host proteins - are of far wider significance, not least in understanding the commoner neurodegenerative diseases that pose such a major and increasing challenge for healthcare in an ageing population.
引用
收藏
页码:906 / 919
页数:14
相关论文
共 139 条
  • [41] PRION DEMENTIA WITHOUT CHARACTERISTIC PATHOLOGY
    COLLINGE, J
    OWEN, F
    POULTER, M
    LEACH, M
    CROW, TJ
    ROSSOR, MN
    HARDY, J
    MULLAN, MJ
    JANOTA, I
    LANTOS, PL
    [J]. LANCET, 1990, 336 (8706) : 7 - 9
  • [42] Prion diseases of humans and animals: Their causes and molecular basis
    Collinge, J
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 519 - 550
  • [43] Human prion diseases and bovine spongiform encephalopathy (BSE)
    Collinge, J
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (10) : 1699 - 1705
  • [44] Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease
    Collinge, J
    Beck, J
    Campbell, T
    Estibeiro, K
    Will, RG
    [J]. LANCET, 1996, 348 (9019) : 56 - 56
  • [45] Collinge J, 1999, DEMENTIA
  • [46] Collins J, 1998, DECISION SCIENCES INSTITUTE 1998 PROCEEDINGS, VOLS 1-3, P113
  • [47] Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study
    Collins, S
    Law, MG
    Fletcher, A
    Boyd, A
    Kaldor, J
    Masters, CL
    [J]. LANCET, 1999, 353 (9154) : 693 - 697
  • [48] Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France
    d'Aignaux, JH
    Costagliola, D
    Maccario, J
    de Villemeur, TB
    Brandel, JP
    Deslys, JP
    Hauw, JJ
    Chaussain, JL
    Agid, Y
    Dormont, D
    Alpérovitch, A
    [J]. NEUROLOGY, 1999, 53 (06) : 1197 - 1201
  • [49] Predictability of the UK variant Creutzfeldt-Jakob disease epidemic
    d'Aignaux, JNH
    Cousens, SN
    Smith, PG
    [J]. SCIENCE, 2001, 294 (5547) : 1729 - 1731
  • [50] Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models
    Doh-Ura, K
    Ishikawa, K
    Murakami-Kubo, I
    Sasaki, K
    Mohri, S
    Race, R
    Iwaki, T
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (10) : 4999 - 5006